MARSHALL WACE, LLP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$765,000
-50.6%
41,904
-50.8%
0.00%
-50.0%
Q4 2020$1,549,000
-19.6%
85,088
-21.2%
0.01%
-33.3%
Q3 2020$1,927,000
-48.0%
108,028
-47.7%
0.01%
-53.8%
Q2 2020$3,707,000
+186.9%
206,752
+143.0%
0.03%
+100.0%
Q1 2020$1,292,000
-65.9%
85,088
-55.7%
0.01%
-50.0%
Q4 2019$3,786,000
-89.3%
191,879
-90.7%
0.03%
-90.7%
Q3 2019$35,428,000
-3.7%
2,059,728
-0.9%
0.28%
-7.9%
Q2 2019$36,799,000
-69.5%
2,079,070
-64.9%
0.30%
-46.8%
Q1 2019$120,762,0005,928,4140.57%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders